missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CD48/SLAMF2 Antibody (CD48/8360R), Novus Biologicals™
  7. 18668314

CD48/SLAMF2 Antibody (CD48/8360R), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-20499-100ug

 View more versions of this product

Product Code. 18668314

  • 530.00 € / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD48/SLAMF2 Monoclonal antibody specifically detects CD48/SLAMF2 in Human samples. It is validated for Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD48/SLAMF2
Monoclonal
0.2 mg/ml
Immunohistochemistry-Paraffin 1-2 μg/mL
BCM1 surface antigen, BCM1Leukocyte antigen MEM-102, BLAST, BLAST1TCT.1, B-lymphocyte activation marker BLAST-1, CD48 antigen, CD48 antigen (B-cell membrane protein), CD48 molecule, hCD48, mCD48, MEM-102, SLAMF2
Recombinant fragment (around aa 59-178) of human CD48/SLAMF2 protein (exact sequence is proprietary)
100 μg
Cell Biology, Cellular Markers, Immunology, Stem Cell Markers
962
Store at 4&drg;C. Do not freeze.
IgG κ
Immunohistochemistry (Paraffin)
CD48/8360R
Unconjugated
10mM PBS with 0.05% BSA
Rabbit
Protein A or G purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.